Adagene to Participate in Three Upcoming Investor Conferences
Adagene Inc., a clinical-stage biotechnology company specializing in antibody-based cancer immunotherapies, announced senior management will participate in three upcoming investor conferences in New York to present their latest clinical developments and strategic collaborations. The company highlighted its proprietary SAFEbody technology and lead c…